Neuroscience金沙手机app平台

金沙平台注册

金沙平台注册

With a rich heritage and a research and development focus on specific aspects of neurodegenerative diseases, analgesia and psychiatry, AstraZeneca continues to push the boundaries of science in neuroscience in collaboration with other innovative partners across industry and academia. A significant unmet medical need remains in the areas of cognitive disorders, chronic pain and other central nervous system disorders. 

 

金沙平台注册

更多 than 450 million people worldwide are affected by mental, neurological or behavioural problems, and the number is steadily rising.

  • 金沙手机app平台

    AD is a fatal illness that causes progressive decline in memory and other aspects of cognition.


    金沙官网注册开户
  • 金沙手机app平台

    OIC is a condition caused by prescription opioid pain medicines. Millions of patients are treated with opioids each year.


    金沙官网金沙注册金沙平台

金沙平台注册

We are committed to developing novel therapies that advance the science of neurodegenerative diseases and have the potential to provide a positive impact on patients around the world.

        Image: Artistic rendering of BACE enzyme.

金沙平台注册

Partnering with influential organisations to extend the reach of our science to 更多 patients and healthcare providers


金沙平台注册

Our approach in Neuroscience looks to maximise revenue through externalisation and on-market products; advance the novel product pipeline with partnerships where appropriate; and preserve a company stake in the most promising assets.


Our pipeline金沙手机app平台

金沙平台注册

金沙平台注册

We cannot provide detailed information about our prescription medicines on this website, in compliance with regulations. Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out more about our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice about medicines.

Diprivan金沙手机app平台

propofol

EMLA金沙手机app平台

EMLA

Movantik/Moventig 金沙手机app平台

naloxegol

Naropin金沙手机app平台

ropivacaine

Seroquel IR金沙手机app平台

quetiapine fumarate

Seroquel XR金沙手机app平台

quetiapine fumarate

Xylocaine金沙手机app平台

lidocaine

Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon 金沙手机app平台

zolmitriptan

金沙平台注册



金沙平台注册

and help us deliver life-changing medicines

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.


Veeva ID: Z4-17491    

Date of next review: 07/06/2021